|
Clinical Trials and Observations
Citations 211-220 of 2742 total displayed.
|
Past content
(since May 1998):
|
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
- Francisco Cervantes, Brigitte Dupriez, Arturo Pereira, Francesco Passamonti, John T. Reilly, Enrica Morra, Alessandro M. Vannucchi, Ruben A. Mesa, Jean-Loup Demory, Giovanni Barosi, Elisa Rumi, and Ayalew Tefferi
Blood 2009; 113: 2895-2901.
[Abstract]
[Full text]
[PDF]
Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation
- Veronika Bachanova, Michael R. Verneris, Todd DeFor, Claudio G. Brunstein, and Daniel J. Weisdorf
Blood 2009; 113: 2902-2905.
[Abstract]
[Full text]
[PDF]
Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
- Bas J. Wouters, Bob Löwenberg, Claudia A. J. Erpelinck-Verschueren, Wim L. J. van Putten, Peter J. M. Valk, and Ruud Delwel
Blood 2009; 113: 3088-3091.
[Abstract]
[Full text]
[PDF]
The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation
- Olle Ringdén, Steven Z. Pavletic, Claudio Anasetti, A. John Barrett, Tao Wang, Dan Wang, Joseph H. Antin, Paolo Di Bartolomeo, Brian J. Bolwell, Christopher Bredeson, Mitchell S. Cairo, Robert P. Gale, Vikas Gupta, Theresa Hahn, Gregory A. Hale, Jorg Halter, Madan Jagasia, Mark R. Litzow, Franco Locatelli, David I. Marks, Philip L. McCarthy, Morton J. Cowan, Effie W. Petersdorf, James A. Russell, Gary J. Schiller, Harry Schouten, Stephen Spellman, Leo F. Verdonck, John R. Wingard, Mary M. Horowitz, and Mukta Arora
Blood 2009; 113: 3110-3118.
[Abstract]
[Full text]
[PDF]
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
- Daniela Pende, Stefania Marcenaro, Michela Falco, Stefania Martini, Maria Ester Bernardo, Daniela Montagna, Elisa Romeo, Céline Cognet, Miryam Martinetti, Rita Maccario, Maria Cristina Mingari, Eric Vivier, Lorenzo Moretta, Franco Locatelli, and Alessandro Moretta
Blood 2009; 113: 3119-3129.
[Abstract]
[Full text]
[PDF]
Age-related Epstein-Barr virus (EBV)–associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients
- Naoko Asano, Kazuhito Yamamoto, Jun-Ichi Tamaru, Takashi Oyama, Fumihiro Ishida, Koichi Ohshima, Tadashi Yoshino, Naoya Nakamura, Shigeo Mori, Osamu Yoshie, Yoshie Shimoyama, Yasuo Morishima, Tomohiro Kinoshita, and Shigeo Nakamura
Blood 2009; 113: 2629-2636.
[Abstract]
[Full text]
[PDF]
Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia
- Mitch A. Phelps, Thomas S. Lin, Amy J. Johnson, Eunju Hurh, Darlene M. Rozewski, Katherine L. Farley, Di Wu, Kristie A. Blum, Beth Fischer, Sarah M. Mitchell, Mollie E. Moran, Michelle Brooker-McEldowney, Nyla A. Heerema, David Jarjoura, Larry J. Schaaf, John C. Byrd, Michael R. Grever, and James T. Dalton
Blood 2009; 113: 2637-2645.
[Abstract]
[Full text]
[PDF]
Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients
- Martina Tschudi, Bernhard Lämmle, and Lorenzo Alberio
Blood 2009; 113: 2402-2409.
[Abstract]
[Full text]
[PDF]
Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors
- Margaret L. MacMillan, Daniel J. Weisdorf, Claudio G. Brunstein, Qing Cao, Todd E. DeFor, Michael R. Verneris, Bruce R. Blazar, and John E. Wagner
Blood 2009; 113: 2410-2415.
[Abstract]
[Full text]
[PDF]
Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia
- Dong Hwan (Dennis) Kim, Wei Xu, Clement Ma, Xiangdong Liu, Katherine Siminovitch, Hans A. Messner, and Jeffrey H. Lipton
Blood 2009; 113: 2517-2525.
[Abstract]
[Full text]
[PDF]
|
|
